Europe ELISA Diagnostics Tests Market Forecast to 2030

Europe ELISA Diagnostics Tests Market Forecast to 2030

Europe ELISA Diagnostics Tests Market Forecast to 2030 – Regional Analysis – by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)

Send Enquiry
Item ID: BMIRE00029815 Category: Tag:

$2,840 – $4,440

Description

The Europe ELISA diagnostics tests market was valued at US$ 319.59 million in 2022 and is expected to reach US$ 534.65 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Increasing Incidence of Human Infections Fuels Europe ELISA Diagnostics Tests Market

According to the WHO Report 2020, noncommunicable and chronic diseases cause the majority of adult deaths worldwide. Over the next ten years, this number is expected to rise by 17%. Roughly one in three persons worldwide deal with several chronic illnesses. Moreover, noncommunicable illnesses account for 41 million annual deaths worldwide, or 74% of all fatalities. Further, 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. With 17.9 million fatalities from NCDs each year, cardiovascular illnesses account for the majority of mortality. Cancer, chronic respiratory diseases, and diabetes follow closely behind. In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.

Europe ELISA Diagnostics Tests Market Overview

According to the Journal of Thoracic Oncology report, lung cancer is responsible to cause significant morbidity, mortality, and socioeconomic cost in Germany. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality in 2020. With an age-standardized incidence rate of 32.7 and 52.1 (per 100,000) in men and women, respectively, lung cancer ranked third in women and second in men in Germany. Therefore, with the rising prevalence of lung cancer in the country, the implementation of lung cancer screening and diagnosis in the German healthcare system is of utmost importance. To control the prevalence of lung cancer in Germany, market players focus on manufacturing ELISA diagnostic tests. QIAGEN N.V. is one such example. In May 2021, QIAGEN N.V. announced the launch of its first FDA-approved companion diagnostic (CDx) claims for the “therascreen KRAS RGQ PCR Kit” to identify non-small cell lung cancer (NSCLC) patients. The therascreen KRAS kit is the first companion diagnostic test to obtain premarket approval from the US Food and Drug Administration (USFDA) to identify the KRAS G12C mutation in samples of NSCLC tumor tissues. Therefore, the rising cancer prevalence, particularly lung cancer in Germany, and innovative product launches by the manufacturers boost the ELISA diagnostic test market growth in Germany.

Europe ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Europe ELISA Diagnostics Tests Market Segmentation

The Europe ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Europe ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Europe ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Europe ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Europe ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Europe ELISA diagnostics tests market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Europe ELISA diagnostics tests market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 6.6% CAGR, the Europe ELISA Diagnostics Tests Market is Speculated to be worth US$ 534.65 million by 2030, Says the Research Team

According to the Research Team’ research, the Europe ELISA diagnostics tests market was valued at US$ 319.59 million in 2022 and is expected to reach US$ 534.65 million by 2030, registering a CAGR of 6.6% from 2022 to 2030. Innovative product launches and advancements in ELISA-based procedures are among the critical factors attributed to the Europe ELISA diagnostics tests market expansion.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. “Human Factor IX Kit” is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests. Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans. In December 2022, Pictor Limited announced a new product launch of the “PictArray SARS-CoV-2 Antibody Test,” which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

On the contrary, incidents of product recalls hamper the growth of Europe ELISA diagnostics tests market.

Based on adoption, the Europe ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held 65.5% market share in 2022, amassing US$ 209.19 million. It is projected to garner US$ 362.51 million by 2030 to expand at 7.1% CAGR during 2022-2030.

In terms of test type, the Europe ELISA diagnostics tests market is categorized into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held 35.4% share of Europe ELISA diagnostics tests market in 2022, amassing US$ 112.99 million. It is projected to garner US$ 207.28 million by 2030 to expand at 7.9% CAGR during 2022-2030.

Based on application, the Europe ELISA diagnostics tests market is categorized into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held 41.3% share of Europe ELISA diagnostics tests market in 2022, amassing US$ 131.92 million. It is projected to garner US$ 237.45 million by 2030 to expand at 7.6% CAGR during 2022-2030.

By end user, the Europe ELISA diagnostics tests market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held 40.4% share of Europe ELISA diagnostics tests market in 2022, amassing US$ 129.09 million. It is projected to garner US$ 230.91 million by 2030 to expand at 7.5% CAGR during 2022-2030.

Based on country, the Europe ELISA diagnostics tests market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.5% share of Europe ELISA diagnostics tests market in 2022. It was assessed at US$ 94.31 million in 2022 and is likely to hit US$ 188.46 million by 2030, exhibiting a CAGR of 9.0% during 2022-2030.

Key players operating in the Europe ELISA diagnostics tests market are Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp., among others.

In Oct 2021, Roche launches comprehensive genomic profiling kit to expand access to personalized cancer research.

In Aug 2021, Danaher Completes Acquisition of Aldevron.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe ELISA diagnostics tests market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe ELISA diagnostics tests market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe ELISA diagnostics tests market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
1.2.1 Europe ELISA Diagnostic Tests Market – by Adoption
1.2.2 Europe ELISA Diagnostic Tests Market – by Test Type
1.2.3 Europe ELISA Diagnostic Tests Market – by Application
1.2.4 Europe ELISA Diagnostic Tests Market – by End User
1.2.5 Europe ELISA Diagnostic Tests Market – by Country
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe ELISA Diagnostic Test Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Infectious Diseases Among Animals
4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
4.3.1 Innovative Product Launches
4.4 Future Trends
4.4.1 Advancements in ELISA-Based Procedures
5. ELISA Diagnostic Tests Market – Europe Market Analysis
5.1 Overview
5.2 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
6. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Adoption
6.1 Overview
6.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
6.3.1 Overview
6.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
6.4.1 Overview
6.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
7.3.1 Overview
7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
7.4.1 Overview
7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
7.5.1 Overview
7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
7.6.1 Overview
7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
8.3.1 Overview
8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
8.4.1 Overview
8.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
8.5.1 Overview
8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
8.6.1 Overview
8.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
9.5.1 Overview
9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Europe: ELISA Diagnostic Tests Market
10.1.1 Europe: ELISA Diagnostic Tests Market, by Country
10.1.1.1 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11. ELISA Diagnostics Test Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Idexx Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danaher Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Innovative Diagnostics SAS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin SpA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Elabscience Biotechnology Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 Bio-Techne Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. Germany ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. France ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 8. France ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. France ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. France ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. UK ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 12. UK ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. UK ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 14. UK ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Italy ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Spain ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. Rest of Europe ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

LIST OF FIGURES

Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 – 2030
Figure 5. Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe: ELISA Diagnostic Tests Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in ELISA diagnostics test Market

The List of Companies – Europe ELISA Diagnostics Tests Market

1. Bio-Rad Laboratories Inc.
2. Idexx Laboratories Inc.
3. F. Hoffmann-La Roche Ltd.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories
6. Danaher Corp.
7. Innovative Diagnostics SAS
8. DiaSorin SpA
9. Elabscience Biotechnology Inc.
10. Bio-Techne Corp.

Reviews

There are no reviews yet.

Be the first to review “Europe ELISA Diagnostics Tests Market Forecast to 2030”